Plainfield – October 27, 2026 -- PairSoft has appointed Vijay Vidiyala, an enterprise software executive with more than 20 years of experience, as Chief Product & Technology Officer (CPTO) to lead its product and engineering teams in building AI-driven solutions for the office of the CFO.

Portland – October 27, 2026 -- Postpartum Support International (PSI) has launched a legal justice program backed by $120,000 in new funding, led by a $100,000 "Decriminalizing Mental Illness" grant from the Sozosei Foundation, the philanthropic arm of healthcare company Otsuka. Two $10,000 gifts from private donors complete the funding.

Columbus – October 27, 2026 -- Vertiv Holdings Co. (NYSE: VRT) has completed its acquisition of Utility Innovation Holdings, Inc., which operates as UtilityInnovation Group (UIG), for approximately $1.45 billion in upfront cash, adding microgrid and behind-the-meter power capabilities for data centers constrained by grid access.

BEAVERTON, Ore. – – October 27, 2026 -- Vernier Science Education has launched the Go Direct Materials Test Frame, a tabletop system priced at an introductory $3,495 that measures forces up to ±4,000 N in college teaching laboratories.

Test frame measures force to 0.18 N and displacement to 0.51 μm

The system records real-time force data up to ±4,000 N and displacement across roughly 0–23 cm. Resolution is 0.18 N for force and 0.51 μm for displacement. Adaptable features accommodate specimens longer than 60 cm.

San Diego – October 27, 2026 -- Atrium Therapeutics (Nasdaq: RNA) has dosed the first patient in Corventis, a Phase 1/2 trial of ATR 1072 in PRKAG2 syndrome, and expects initial proof-of-concept data in the second half of 2027.

WASHINGTON – October 27, 2026 -- Vanda Pharmaceuticals (Nasdaq: VNDA) reported that NEREUS (tradipitant) cut the incidence of semaglutide-induced vomiting by 27% in a Phase III trial. Vomiting occurred in 43.0% of treated participants (61/142) versus 58.5% on placebo (96/164), with a p-value of 0.006.

The company plans to discuss the data with the U.S. Food and Drug Administration (FDA). It intends to file a supplemental New Drug Application (sNDA) for preventing vomiting associated with GLP-1 receptor agonist therapy.

NEW YORK – October 27, 2026 -- Sales hiring through Multiplier grew 108% over the past year, more than double the platform's 53% overall hiring growth, according to the company's new Talent Trends data. The analysis covers more than 38,000 hires across 2,700+ companies.

Raleigh – October 27, 2026 -- Cardinal Infrastructure Group, Inc. (NASDAQ: CDNL) will release its third-quarter 2026 financial results before markets open on Thursday, November 12, 2026.

Management will hold a conference call the same day at 10:30 ET. The company will post a webcast, a presentation, a press release and additional financial information on its website before the call, and a replay will be available at the same location shortly after the presentation ends.

Jersey City – October 27, 2026 -- Oishii, operator of what it calls the world's largest indoor vertical Smart Farm, will reach more than 500 U.S. retail locations across 25 states by the end of 2026, more than doubling its points of distribution, after adding Walmart, The Fresh Market and Giant Food as first-time retail partners.

INDIANAPOLIS – October 27, 2026 -- Carnyx Therapeutics has advanced its lead oral sleep candidate, CNYX-005, into Investigational New Drug (IND)-enabling development, bringing the preclinical asset closer to potential first-in-human studies.